Year in Review: Non-Small Cell Lung Cancer
The top stories in non-small cell lung cancer (NSCLC) for 2024 included practice-changing results in EGFR-mutant disease, an unprecedented gain ...
Month: November 2024
MS Drugmaker Fined €462.6 Million for Disparaging Rival
The European Commission (EC) has fined pharmaceutical company Teva €462.6 million for “systematically spread misleading information” and abusing its dominant ...
Texas Hospitals Must Now Ask Patients Whether They Are in the U.S. Legally
Texas hospitals must ask patients starting Friday whether they are in the U.S. legally and track the cost of treating ...
Does an Additional First-Line Option Alter Approach in EGFR-Mutant NSCLC?
In August, the FDA approved another first-line treatment option for patients with EGFR-mutant non-small cell lung cancer (NSCLC): the third-generation ...
Taking on Acquired Resistance in EGFR-Mutant NSCLC
The majority of people with advanced EGFR-mutant non-small cell lung cancer (NSCLC) receiving first-line osimertinib (Tagrisso) will respond to therapy. ...
Residency Applications Down
Fourth-year medical student William Keller, who asked Medscape not to use his real name, is interviewing with residency programs. He ...
MedPod Today: Upcoding Concerns; COVID Vax Recs; Med School Credit for Parenting
The following is a transcript of the podcast episode: Rachael Robertson: Hey everybody. Welcome to MedPod Today, the podcast series ...
Novel Intervention Slows Cognitive Decline in At-Risk Adults
Combining cognitive remediation (CR) with transcranial direct current stimulation (tDCS) was associated with slower cognitive decline for up to 6 ...
Dermatologists Sound Alarm as Scabies Cases Rise
TOPLINE:The British Association of Dermatologists is alerting the public and clinicians about an unusual increase in scabies cases thus far ...
Emerging Insights Into COVID Household Transmission
Since early in the COVID-19 pandemic, epidemiologic studies demonstrated that household transmission was a key driver in the spread of ...
Women ‘Celebrating’ Their Abortions? Librarians’ Mental Health; $500M Drugmaker Fine
Note that some links may require registration or subscription. In an interview with podcaster Joe Rogan, Sen. JD Vance (R-Ohio) ...
GPs demand exemption from Budget tax hike for firms
GPs are calling on the government to exempt them from tax rises for employers announced at the Budget, warning it ...
GLP-1s Show No Link to AKI With Anticancer Therapy
SAN DIEGO – Patients receiving cancer treatment, while having an increased risk for acute kidney injury (AKI) linked to various ...
Need a CMO? Fractional Health Executives Are a Win-Win
N. Adam Brown is a practicing emergency physician, entrepreneur, and healthcare executive. He is the founder of ABIG Health, a ...
Cannabis Substitution for Medications: How Often and Why
Nearly two thirds of patients with rheumatic conditions switched to medical cannabis from medications such as nonsteroidal anti-inflammatory drugs (NSAIDs) ...
Outpatient CAR T: Safe, Effective, Accessible
A growing body of research suggests that clinicians can offer chimeric antigen receptor (CAR) T-cell therapy safely and effectively on ...
Weight Loss Surgery, Obesity Drugs Achieve Similar Results
PHILADELPHIA — Roux-en-Y gastric bypass (RYGB) produces maximal weight loss in patients with obesity compared with other surgical procedures and ...
No Visual Benefit, Higher Diabetes Risk
TOPLINE: In patients with giant cell arteritis (GCA), intravenous methylprednisolone compared with oral glucocorticoids alone does not improve visual acuity and ...
Cosmetic Dermatology Product Recalls Still Common
TOPLINE:Between 2011 and 2023, the US Food and Drug Administration (FDA) reported recalls of 334 cosmetic dermatology products in the ...
Use of New DMARDs for JIA Rose Steadily in Past 20 Years
TOPLINE:The use of newer biologic or targeted synthetic disease-modifying antirheumatic drugs (b/tsDMARDs) for treating juvenile idiopathic arthritis (JIA) rose sharply ...
